ECG criteria for the detection of high-risk cardiovascular conditions in master athletes.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 31 1 2020
medline: 25 8 2021
entrez: 31 1 2020
Statut: ppublish

Résumé

Structured electrocardiography (ECG) analysis is used to screen athletes for high-risk cardiovascular conditions (HRCC) to prevent sudden cardiac death. ECG criteria have been specified and recommended for use in young athletes ≤ 35 years. However, it is unclear whether these ECG criteria can also be applied to master athletes >35 years. The purpose of this study was to test whether the existing ECG criteria for detecting HRCC in young athletes can be applied to master athletes. We conducted a cross-sectional study among athletes >35 years screened for HRCC between 2006 and 2010. We performed a blinded retrospective analysis of master athletes' ECGs, separately applying European Society of Cardiology (ESC)-2005, Seattle, and International criteria. HRCC were defined using recommendations from the international cardiac societies American Heart Association and American College of Cardiology, and ESC, based on ECG screening and cardiovascular evaluation (CVE). We included 2578 master athletes in the study, of whom 494 had initial screening abnormalities mandating CVE. Atrial enlargement (109, 4.1%) and left ventricular hypertrophy (98, 3.8%) were the most common ECG abnormalities found using the ESC-2005 or Seattle criteria. Applying the International criteria, ST-segment deviation (66, 2.6%), and T-wave inversion (58, 2.2%) were most frequent. The ESC-2005 criteria detected more HRCC (46, 1.8%) compared with the Seattle (36, 1.4%) and International criteria (33, 1.3%). The most frequently detected HRCC was coronary artery disease (24, 0.9%). ECG criteria recommended for use in young athletes can be applied to master athletes' ECGs to detect HRCC. The ESC-2005 criteria had the highest sensitivity for detecting HRCC among master athletes.

Identifiants

pubmed: 31996014
doi: 10.1177/2047487319901060
pmc: PMC7469710
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1529-1538

Commentaires et corrections

Type : CommentIn

Références

Circulation. 2017 Jul 11;136(2):138-148
pubmed: 28450347
Br J Sports Med. 2013 Feb;47(3):137-52
pubmed: 23303760
J Am Coll Cardiol. 2008 Oct 7;52(15):1231-8
pubmed: 18926326
Neth Heart J. 2018 Mar;26(3):127-132
pubmed: 29392521
J Electrocardiol. 2015 May-Jun;48(3):324-8
pubmed: 25771161
N Engl J Med. 2012 Jan 12;366(2):130-40
pubmed: 22236223
Eur Heart J. 2005 Mar;26(5):516-24
pubmed: 15689345
Eur Heart J. 2018 Apr 21;39(16):1466-1480
pubmed: 28329355
Circulation. 2015 Apr 21;131(16):1384-91
pubmed: 25847988
Br J Sports Med. 2017 Feb;51(3):153-167
pubmed: 27660369
Clin J Sport Med. 2016 Sep;26(5):369-75
pubmed: 26886802
Circulation. 2017 Jul 11;136(2):126-137
pubmed: 28465287
Eur Heart J. 2010 Jan;31(2):243-59
pubmed: 19933514
Eur Heart J. 2008 Aug;29(15):1903-10
pubmed: 18426850
Int J Cardiol. 2019 May 1;282:99-107
pubmed: 30482442
Eur Heart J. 2012 Nov;33(21):2639-43
pubmed: 22645193
BMJ Open Sport Exerc Med. 2018 Aug 9;4(1):e000370
pubmed: 30112182
Eur Heart J. 2005 Jul;26(14):1422-45
pubmed: 15923204
Am J Med. 2011 Jun;124(6):511-8
pubmed: 21605728
Circulation. 2017 Jul 11;136(2):149-151
pubmed: 28696264
Eur Heart J. 2012 Oct;33(20):2569-619
pubmed: 22922416
Br J Sports Med. 2011 Aug;45(10):776-9
pubmed: 19858111
Circulation. 2015 Dec 1;132(22):e267-72
pubmed: 26527714
Heart. 2015 Mar;101(5):384-90
pubmed: 25502812
J Am Coll Cardiol. 2015 Dec 1;66(21):2343-2349
pubmed: 26542655
Br J Sports Med. 2013 Feb;47(3):122-4
pubmed: 23303758
Eur J Prev Cardiol. 2019 Apr;26(6):641-652
pubmed: 30426769
N Engl J Med. 2008 May 8;358(19):2016-23
pubmed: 18463377
J Am Coll Cardiol. 2015 Feb 10;65(5):493-502
pubmed: 25660928
Br J Sports Med. 2013 Feb;47(3):153-67
pubmed: 23303761

Auteurs

Nicole M Panhuyzen-Goedkoop (NM)

Heart Centre, Amsterdam University Medical Centers, AMC Amsterdam, the Netherlands.
Sports Medical Centre Papendal, Arnhem, the Netherlands.

Hein J Wellens (HJ)

Cardiac Research Centre Maastricht, the Netherlands.

André Lm Verbeek (AL)

Health Evidence, Radboud University Medical Centre, Nijmegen, the Netherlands.

Harald T Jørstad (HT)

Heart Centre, Amsterdam University Medical Centers, AMC Amsterdam, the Netherlands.

Joep Rlm Smeets (JR)

Heart Centre, Radboud University Medical Centre, Nijmegen, the Netherlands.

Ron Jg Peters (RJ)

Heart Centre, Amsterdam University Medical Centers, AMC Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH